Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II)

Bone Marrow Transplantation

Volumn 27, Issue 2, 2001, Pages 213-215

  Iolascon, A ^a   Sabato, V ^a   De Mattia, D ^a   Locatelli, F ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Anaemia; Bone marrow transplantation; CDA; Congenital dyserythropoietic anaemia type II; Dyserythropoiesis; Iron overload

Indexed keywords

BETA GLOBIN; BUSULFAN; CYCLOSPORIN A; DNA; FERRITIN; FLUDARABINE; HEMOGLOBIN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; IRON CHELATING AGENT; METHOTREXATE; THIOTEPA;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BETA THALASSEMIA; BLOOD TRANSFUSION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY STUDY; FEMALE; GALLBLADDER DISEASE; GRAFT VERSUS HOST REACTION; HEMOCHROMATOSIS; HEPATOMEGALY; HEREDITARY HEMOLYTIC ANEMIA; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON CHELATION; JAUNDICE; MALE; PATIENT COMPLIANCE; PEDIGREE; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BONE MARROW TRANSPLANTATION; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035134171     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702764     Document Type: Article

References (15)

1. Congenital dyserythropoietic anemia type II. Ultrastructural and radioautographic studies of blood and bone marrow
2. The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anaemia (Type II) originate from the endoplasmic reticulum
3. Exclusion of three candidate genes as determinants of congenital dyserithropoietic anemia type II (CDA II)
4. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search
5. Genetic heterogeneity of congenital dyserythropoietic anemia II (CDA II)
6. Congenital dyserythropoietic anemia type II: Molecular basis and clinical aspects
7. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia
8. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region
9. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy
10. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma
11. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-host leukemia without myeloablative therapy
12. Fludarabine-based preparative protocol for unrelated cord blood transplantation in children: Successful engraftment with minimal toxicity
13. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies
14. Efficacy of fludarabine as immunosuppressor for bone marrow transplantation conditioning
15. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anaemia